Prognostic impact of platelet/lymphocyte and neutrophil/lymphocyte ratios in patients with gastric cancer: A multicenter study

International Journal of Clinical and Experimental Medicine

Volumn 8, Issue 4, 2015, Pages 5937-5942

  Gunaldi, Meral ^a   Goksu, Sema ^b   Erdem, Dilek ^c   Gunduz, Seyda ^b   Okuturlar, Yildiz ^a   Tiken, Eda ^a   Kahraman, Sibel ^a   Inan, Yesim Ozdem ^a   Genc, Tugrul Burak ^a   Yildirim, Mustafa ^c  

^a BAKIRKOY DR SADI KONUK TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b Kayseri Research and Training Hospital ^*  (Turkey)

^c MEDICAL PARK HOSPITAL   (Turkey)

Author keywords

Gastric cancer; Neutrophil lymphocyte ratio; Platelet lymphocyte ratio; Systemic inflammatory response

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEUTROPHIL LYMPHOCYTE RATIO; PLATELET LYMPHOCYTE RATIO; PREDICTIVE VALUE; PROGNOSTIC ASSESSMENT; SURVIVAL TIME; TUMOR INVASION; TUMOR VOLUME;

EID: 84931275136     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Herszenyi L, Tulassay Z. Epidemiology of gastrointestinal and liver tumors. Eur Rev Med Pharmacol Sci 2010; 14: 249-58.
2. Hundahl SA, Phillips JL, Menck HR. The National Cancer Data Base Report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy: Fifth Edition American Joint Committee on Cancer staging, proximal disease, and the “different disease” hypothesis. Cancer 2000; 88: 921.
3. Gwak MS, Choi SJ, Kim JA, Ko JS, Kim TH, Lee SM, Park JA, Kim MH. Effects of gender on white blood cell populations and neutrophil-lymphocyte ratio following gastrectomy in patients with stomach cancer. J Korean Med Sci 2007; 22: 104-8.
4. Atzpodien J, Royston P, Wandert T, Reitz M; DGCIN-German Cooperative Renal Carcinoma Chemo-Immunotherapy Trials Group. Metas-tatic renal carcinoma comprehensive prognostic system. Br J Cancer 2003; 88: 348-53.
5. Schmidt H, Bastholt L, Geertsen P, Christensen IJ, Larsen S, Gehl J, von der Maase H. Elevated neutrophil and monocyte counts in peripheral blood are associated with poor survival in patients with metastatic melanoma: a prognostic model. Br J Cancer 2005; 93: 273-8.
6. Fogar P, Sperti C, Basso D, Sanzari MC, Greco E, Davoli C, Navaglia F, Zambon CF, Pasquali C, Venza E, Pedrazzoli S, Plebani M. Decreased total lymphocyte counts in pancreatic cancer: an index of adverse outcome. Pancreas 2006; 32: 22-8.
7. Walsh SR, Cook EJ, Goulder F, Justin TA, Keeling NJ. Neutrophillymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol 2005; 91: 181-4.
8. Hussein MR, Ahmed RA. Analysis of the mononuclear inflammatory cell infiltrates in the non-tumorigenic, pre-tumorigenic and tumorigenic keratinocytic hyperproliferative lesions of the skin. Cancer Biol Ther 2005; 4: 819-21.
9. Aliustaoglu M, Bilici A, Ustaalioglu BB, Konya V, Gucun M, Seker M, Gumus M. The effect of peripheral blood values on prognosis of patients with locally advanced gastric cancer before treatment. Med Oncol 2010; 27: 1060-5.
10. Pollard JW. Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 2004; 4: 71-78.
11. Forrest LM, McMillan DC, McArdle CS, Angerson WJ, Dunlop DJ. Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer. Br J Cancer 2003; 89: 1028-30.
12. Jiang N, Deng JY, Liu Y, Ke B, Liu HG, Liang H. The role of preoperative neutrophil-lymphocyte and platelet-lymphocyte ratio in patients after radical resection for gastric cancer. Biomarkers 2014; 19: 444-51.
13. Graziosi L, Marino E, De Angelis V, Rebonato A, Cavazzoni E, Donini A. Prognostic value of preoperative neutrophils to lymphocytes ratio in patients resected for gastric cancer. Am J Surg 2014; 209: 333-7.
14. Matowicka-Karna J, Kamocki Z, Polińska B, Osada J, Kemona H. Platelets and inflammatory markers in patients with gastric cancer. Clin Dev Immunol 2013; 2013: 401623.
15. Li QQ, Lu ZH, Yang L, Lu M, Zhang XT, Li J, Zhou J, Wang XC, Gong JF, Gao J, Li J, Li Y, Shen L. Neutrophil count and the inflammation-based glasgow prognostic score predict survival in patients with advanced gastric cancer receiving first-line chemotherapy. Asian Pac J Cancer Prev 2014; 15: 945-50.
16. Kaya V, Yıldırım M, Demirpence Ö, Yıldız M, Yalçın AY. Prognostic Signifiance of Basic Laboratory Methods in Non-Small Cell Lung Cancer. Asian Pac J Cancer Prev. Asian Pac J Cancer Prev 2013; 14: 5473-6.
17. Yamanaka T, Matsumoto S, Teramukai S, Ishiwata R, Nagai Y, Fukushima M. The baseline ratio of neutrophils to lymphocytes with patient prognosis in advanced gastric cancer. Oncology 2007; 73: 215-20.
18. Smith RA, Ghaneh P, Sutton R, Raraty M, Campbell F, Neoptolemos JP. Prognosis of resected ampullary adenocarcinoma by preoperative serum CA19-9 levels and platelet-lymphocyte ratio. J Gastrointest Surg 2008; 12: 1422-8.
19. Alikanoğlu AS, Yıldırım M, Süren D, Yıldız M, Sezer C, Göktaş S, Bülbüller N. HER 2 expression in gastric cancer. J Clin Anal Med 2013; 4: 269-72.
20. Yıldırım M, Süren D, Göktaş S, Utku Dilli U.D, Kaya Ç, Çopuroǧlu R, Yıldız M, Sezer C. The predictive role Of Bcl-2 expression in metastatic gastric carcinoma. J BUON 2012; 17: 106-9.
21. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet 2001; 357: 539-545.
22. Xu AM, Huang L, Zhu L, Wei ZJ. Significance of peripheral neutrophil-lymphocyte ratio among gastric cancer patients and construction of a treatment-predictive model: a study based on 1131 cases. Am J Cancer Res 2014; 4: 189-95.
23. Shimada H, Takiguchi N, Kainuma O, Soda H, Ikeda A, Cho A, Miyazaki A, Gunji H, Yamamoto H and Nagata M. High preoperative neutrophil-lymphocyte ratio predicts poor survival in patients with gastric cancer. Gastric Cancer 2010; 13: 170-176.
24. Xu J, Qiu T, Wang J, Wang T, Zhu W, Liu P. Prognostic value of PLR in various cancers: a meta-analysis. PLoS One 2014; 9: e101119.
25. Bambace NM, Holmes CE. The platelet contribution to cancer progression. J Thromb Haemost 2011; 9: 237-249.
26. Wiesner T, Bugl S, Mayer F, Hartmann JT, Kopp HG. Differential changes in platelet VEGF, Tsp, CXCL12 and CXCL4 in patients with metastatic cancer. Clin Exp Metastasis 2010; 27: 141-149.